Fast-tracked psychedelics hit a wall: why the FDA’s pause on psilocybin is an important check to ensure safety, rigor, and ...
“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...
Marc Goodman Leerink Partners LLC, Research Division. Okay. We're going to get going on our next session. Thanks for joining us. I'm Marc Goodman, one of the biopharma analyst at ...
Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing activity to abnormal levels. Up is down and down is up. The right molecule ...
This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
A social media post from the U.S. Food and Drug Administration this week shows a big-eyed macaque staring out from behind ...
One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results